Leukemia, Myelodysplasia, Transplantation
Reviews
Molecular monitoring and minimal residual disease in the management of chronic myelogenous leukemia
From the Editor
Taking the data and findings into the real-world setting
News
Refugees struggle to access cancer treatment
Credit: UK Department for International Development A new study published in The Lancet Oncology reveals a high demand for costly cancer...
News
Drug gets orphan designation for CLL/SLL
The US Food and Drug Administration (FDA) has granted orphan designation for MOR208, an anti-CD19 monoclonal antibody, for the treatment of...
News
Cancer trial publications often omit minority accrual rates
Credit: Rhoda Baer A review of clinical trial data from 2012 suggests Hispanic patients are underrepresented in US cancer studies, and many trial...
News
Drug granted orphan designation for AML
The US Food and Drug Administration (FDA) has granted selinexor (KPT-330) orphan designation for the treatment of acute myeloid leukemia (AML)....
News
CHF screening guidelines need another look, group says
patient and her father Credit: Rhoda Baer New research suggests a need to revisit cardiac screening guidelines for survivors of childhood cancers...
News
Chip may allow for early cancer detection
Institute of Photonic Sciences Scientists say they’ve developed a lab-on-a-chip device capable of detecting protein markers for cancer. The...
News
Protein may be therapeutic target for AML
Credit: Lance Liotta Researchers have found evidence to suggest that the phosphoinositide (PI) modulator PIP4K2A plays a key role in acute...
News
How cancer-fighting protein is held in check
Credit: A.T.
News
Group finds cancer stem cells in MDS patients
Credit: NIH A new study provides “conclusive evidence” to support the existence of cancer stem cells in patients with myelodysplastic syndromes (...